Erion Lipo
Consultant, EVERSANA MANAGMENT CONSULTING
Expertise:
Erion is a Consultant at EVERSANA MANAGEMENT CONSULTING, with a background in microbiology research, genetics, and molecular biology. Erion has leveraged his foundational academic knowledge to perform market research, develop pipeline prioritization strategies, and conduct competitive intelligence on behalf of medical device and pharmaceutical companies.
In his doctoral thesis at Tufts University, Erion focused on integrating transcriptomics with proteomics to reveal mechanisms of translation during pathogenic infection, which resulted in two peer-reviewed publications. Prior to this role, Erion was a Research Technician at Tufts University, where he developed viral and non-viral gene therapies for ocular diseases, which resulted in three peer-reviewed publications. Erion earned his bachelor’s degree in psychology from Boston University.
Articles by Erion Lipo
Navigating the Frontier: Generative AI Revolutionizing Healthcare and Life Sciences
In the dynamic landscape of healthcare and life sciences, the integration of cutting-edge technologies has become paramount. Among these innovations, Artificial Intelligence (AI) stands out as a transformative force, reshaping everything from drug discovery to patient care. In this white paper, Tanuj Mehra, Jordan Schell, Erion Lipo and Kevin Yin shed light on the pivotal […]
Social Determinants of Health – What Pharma Can Do!
The US Department of Health and Human Services defines Social Determinants of Health (SDoH) as conditions in the places where people live, learn, work, and play that affect a wide range of health risks and outcomes.1 They can be grouped into five major categories: economic stability, education access and quality, healthcare access and quality, neighborhood […]